| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/07/2013 | WO2013030119A1 Dosage form having stabilized active-ingredient particles |
| 03/07/2013 | WO2013030111A1 Structural mimetics of proline-rich peptides and use thereof |
| 03/07/2013 | WO2013030110A1 Method for producing indanone derivatives |
| 03/07/2013 | WO2013030058A1 Use of diclofenac |
| 03/07/2013 | WO2013029762A1 Morphinan-derivatives for treating diabetes and related disorders |
| 03/07/2013 | WO2013029723A1 Novel photoactivatable paclitaxel derivatives and uses thereof, in particular in cellbiology and cancer treatment |
| 03/07/2013 | WO2013029648A1 New aminoacid compounds for treating tumours and autoimmune diseases |
| 03/07/2013 | WO2013029555A1 Lavendustin a derivatives, preparation method and use thereof |
| 03/07/2013 | WO2013029548A1 Quinolone compound |
| 03/07/2013 | WO2013029525A1 Pharmaceutical composition comprising iodine polymer and glucocorticosteroid for treating dermatitis |
| 03/07/2013 | WO2013029479A1 Mycophenolic acid derivative and preparation method and use thereof |
| 03/07/2013 | WO2013029431A1 Benzodiazepine derivatives tosylate salts, their polymorphic forms, preparation methods and uses thereof |
| 03/07/2013 | WO2013029338A1 Novel compounds |
| 03/07/2013 | WO2013029297A1 Use of patchouli alcohol in preparation of drug against helicobacter pylori |
| 03/07/2013 | WO2013029198A1 Adefovir dipivoxil solid formulation and preparation method therefor |
| 03/07/2013 | WO2013029194A1 Use of non-steroidal anti-inflammatory drugs meloxicam and piroxicam, administered intravaginally, for interruption of a woman's ovulation process |
| 03/07/2013 | WO2013029136A1 Tianeptine derivatives, pharmaceutical compositions, use, and method for producing same |
| 03/07/2013 | WO2013029116A1 Method for predicting treatment responsiveness |
| 03/07/2013 | WO2013011166A3 Use of a composition in the production of a dialysis solution for the treatment of cerebrovascular diseases by means of peritoneal dialysis |
| 03/07/2013 | WO2013010137A3 A composition, device and method for delayed and sustained release of brain energy molecules |
| 03/07/2013 | WO2013010089A3 Inhibitors of bacterial type iii secretion system |
| 03/07/2013 | WO2013009519A3 Materials for treating and preventing mucosa related disease |
| 03/07/2013 | WO2013008253A3 Imatinib formulations |
| 03/07/2013 | WO2013008250A3 Crystalline form of retigabine and processes for mixture of retigabine crystalline modifications |
| 03/07/2013 | WO2013008240A8 Liposomes co-encapsulating a bisphosphonate and an amphipathic agent |
| 03/07/2013 | WO2013004995A8 Pyrimidinone compounds and their use |
| 03/07/2013 | WO2013003298A3 Inhibitors of pde10 |
| 03/07/2013 | WO2013001505A3 Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases |
| 03/07/2013 | WO2012177678A3 Isotopologues of pomalidomide |
| 03/07/2013 | WO2012169849A3 Eye-drop composition for preventing or treating ocular diseases |
| 03/07/2013 | WO2012169827A3 Composition for eyelash growth |
| 03/07/2013 | WO2012166665A3 Broad spectrum antibiotics |
| 03/07/2013 | WO2012163501A9 Nasal pharmaceutical formulation |
| 03/07/2013 | WO2012159593A9 A combined oral formulation with controlled release of acetylsalicylic acid and a method for the preparation |
| 03/07/2013 | WO2012158127A3 Water-soluble formulations comprising dexketoprofen |
| 03/07/2013 | WO2012156537A9 Lysine demethylase inhibitors such as cyclylcylopropamine derivatives for use in the treatment of thrombosis and cardiovascular diseases |
| 03/07/2013 | WO2012144938A3 Composition of protectors of acute and chronic hepatic encephalopathy and method for treating acute and chronic hepatic encephalopathy |
| 03/07/2013 | WO2012144854A3 Novel uses of licochalcone a |
| 03/07/2013 | WO2012141553A3 Stabilizing composition for tetrahydrobiopterin, and method for analyzing tetrahydrobiopterin using same |
| 03/07/2013 | WO2012138713A3 Multifunctional radical quenchers for the treatment of mitochondrial dysfunction |
| 03/07/2013 | WO2012134184A3 Novel cephalosporin derivative and medical composition containing same |
| 03/07/2013 | WO2012117000A8 3-amino-pyridines as gpbar1 agonists |
| 03/07/2013 | WO2012112730A3 Compositions and methods for delivering nucleic acid to a cell |
| 03/07/2013 | WO2012102562A3 Composition containing novel 4-ｏ-methylhonokiol derivative as active ingredient for treatment of dementia |
| 03/07/2013 | WO2012096545A3 Novel pancreatic cancer biomarker using the characteristics of pancreatic cancer stem cells, and use thereof |
| 03/07/2013 | WO2012028332A8 Pharmaceutically active compounds as axl inhibitors |
| 03/07/2013 | US20130061339 Method of diagnosing trichotillomania and similar disorders in humans and rodents |
| 03/07/2013 | US20130060208 Wound care products |
| 03/07/2013 | US20130060039 Azabicyclic carbamates and their use as alpha-7 nicotinic acetylcholine receptor agonists |
| 03/07/2013 | US20130059922 Anti-tumor plant-medicament sustained-release tablet of elemene |
| 03/07/2013 | US20130059921 Use of essential oil of oregano and of rosewood, or constituents thereof, in the therapeutic treatment of keratoses |
| 03/07/2013 | US20130059920 Hydroxytyrosol benefits muscle differentiation and muscle contraction and relaxation |
| 03/07/2013 | US20130059919 Therapeutic Compounds |
| 03/07/2013 | US20130059918 Throat irritation relief beverage |
| 03/07/2013 | US20130059917 Modified release dosage form comprising desvenlafaxine or salts thereof |
| 03/07/2013 | US20130059916 Biguanide compounds and its use for treating cancer |
| 03/07/2013 | US20130059915 Treatment of pain with topical diclofenac |
| 03/07/2013 | US20130059914 Compositions Comprising Enzyme-Cleavable Amphetamine Prodrugs and Inhibitors Thereof |
| 03/07/2013 | US20130059913 Composition for amelioration of hypoalbuminemia |
| 03/07/2013 | US20130059912 Nitrated-fatty acids modulation of type ii diabetes |
| 03/07/2013 | US20130059911 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof |
| 03/07/2013 | US20130059910 Conjugates comprising a gaba- or glycine compound, pharmaceutical compositions and combinations thereof as well as their use in treating cns disorders |
| 03/07/2013 | US20130059908 Sulfonamides for the prevention of diabetes |
| 03/07/2013 | US20130059907 Wogonin-containing pharmaceutical composition for inhibiting cancer stem cells growth and application thereof |
| 03/07/2013 | US20130059906 Methods and compositions for influencing tumors using microrna-185 as a tumor suppressor |
| 03/07/2013 | US20130059904 Methods, agents, and compound screening assays for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
| 03/07/2013 | US20130059903 Compositions and Methods for Characterizing Breast Cancer |
| 03/07/2013 | US20130059902 Methods and compositions useful in treatment of diseases or conditions related to repeat expansion |
| 03/07/2013 | US20130059901 Pre-MRNA Trans-Splicing Molecule (RTM) Molecules and Their Uses |
| 03/07/2013 | US20130059900 Crystal form i of (s)-4-hydroxy-2-oxo-1-pyrrolidine acetamide, preparing method and use thereof |
| 03/07/2013 | US20130059899 Methods of identifying modulators of gpr17 |
| 03/07/2013 | US20130059898 7-azoniabicyclo [2.2.1] heptane derivatives, methods of production, and pharmaceutical uses thereof |
| 03/07/2013 | US20130059897 Rapid release irbesartan-containing pharmaceutical composition |
| 03/07/2013 | US20130059896 5-(1h-pyrazol-5-yl)thiazole-based compounds for the treatment of diseases and disorders of the eye |
| 03/07/2013 | US20130059895 2',2-dithiazol non-nucleoside compounds, preparation methods, pharmaceutical compositions and uses as hepatitis virus inhibitors thereof |
| 03/07/2013 | US20130059893 Crystalline form of the sodium salt of 4-tert-butyl-n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzenesulfonamide |
| 03/07/2013 | US20130059892 Compositions and Methods for Cancer Detection and Treatment |
| 03/07/2013 | US20130059891 Substituted n-heterocycloalkyl bipyrrolidinylphenyl amide derivatives, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059890 Antiviral agents |
| 03/07/2013 | US20130059889 Anhydrous lenalidomide form-i |
| 03/07/2013 | US20130059888 Medicament for prophylactic and/or therapeutic treatment of alzheimer-type dementia |
| 03/07/2013 | US20130059887 Substituted pyridoxine-lactam carboxylate salts |
| 03/07/2013 | US20130059886 Polymorphic form of fexofenadine hydrochloride, intermediates and process for its preparation |
| 03/07/2013 | US20130059885 Method For Preparation Of Pitavastatin and Pharmaceutical Acceptable Salts Thereof |
| 03/07/2013 | US20130059884 Inhibitor of the differentiation of t cells into th1 cells |
| 03/07/2013 | US20130059883 Compounds and methods |
| 03/07/2013 | US20130059882 8-Phenylisoquinolines And Pharmaceutical Composition Used In Treatment For Sepsis |
| 03/07/2013 | US20130059881 Compositions and methods for treating viral diseases |
| 03/07/2013 | US20130059880 Moxifloxacin hydrochloride compounds and intermediates and methods for making same |
| 03/07/2013 | US20130059879 Small Molecule Inhibitors of PFKFB3 and Glycolytic Flux and Their Methods of Use as Anti-Cancer Therapeutics |
| 03/07/2013 | US20130059878 Treatment of diseases modulated by a h4 receptor agonist |
| 03/07/2013 | US20130059877 Treatment of solid tumors with rapamycin derivatives |
| 03/07/2013 | US20130059876 Liquid nasal spray containing low-dose naltrexone |
| 03/07/2013 | US20130059875 Methods of treating traveler's diarrhea and hepatic encephalopathy |
| 03/07/2013 | US20130059874 Substituted n-phenyl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059873 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 03/07/2013 | US20130059872 Polymorphs of alogliptin benzoate |
| 03/07/2013 | US20130059871 Pyrimidine derivatives for the treatment of amyloid-related diseases |
| 03/07/2013 | US20130059870 Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938 |
| 03/07/2013 | US20130059869 Methods and compositions for treating disorders |